Evidence map›Paper›PMID 33987447›Full record

Observational studyJournal of immunology research2021

SLAM/SAP Decreased Follicular Regulatory T Cells in Patients with Graves' Disease.

Lina Geng, Jun Yang, Xinyi Tang, Huiyong Peng, Jie Tian, Zhigang Hu, Yingzhao Liu, Huaxi Xu, Shengjun Wang

Open access · goldAbstract readObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in Journal of immunology research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Lina GengDepartment of Laboratory Medicine, Affiliated People's Hospital, Jiangsu University, Zhenjiang, China.
Jun YangDepartment of Laboratory Medicine, Affiliated People's Hospital, Jiangsu University, Zhenjiang, China.
Xinyi TangDepartment of Laboratory Medicine, Affiliated People's Hospital, Jiangsu University, Zhenjiang, China.
Huiyong PengDepartment of Laboratory Medicine, Affiliated People's Hospital, Jiangsu University, Zhenjiang, China.
Jie TianInstitute of Laboratory Medicine, Jiangsu Key Laboratory for Laboratory Medicine, Jiangsu University School of Medicine, Zhenjiang, China.
Zhigang HuDepartment of Laboratory Medicine, Wuxi Children's Hospital, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi 214023, China.ORCID https://orcid.org/0000-0001-5678-2492
Yingzhao LiuDepartment of Endocrinology, Affiliated People's Hospital, Jiangsu University, Zhenjiang, China.ORCID https://orcid.org/0000-0002-6383-6345
Huaxi XuInstitute of Laboratory Medicine, Jiangsu Key Laboratory for Laboratory Medicine, Jiangsu University School of Medicine, Zhenjiang, China.
Shengjun WangDepartment of Laboratory Medicine, Affiliated People's Hospital, Jiangsu University, Zhenjiang, China.ORCID https://orcid.org/0000-0001-6584-1183
Jiangsu University · CNWuxi People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Signaling lymphocytic activation molecule (SLAM) and SLAM-associated protein (SAP) play important role in inflammatory and autoimmune diseases. Our study is aimed at detecting the expression of SLAM and SAP in patients with Graves' disease (GD) and analyzing the effect of SLAM/SAP on circulating blood CD4

Indexed as

AdultB-LymphocytesCase-Control StudiesFemaleGraves DiseaseHealthy VolunteersHumansLymphocyte CountMaleMiddle AgedSignaling Lymphocytic Activation Molecule Associated ProteinSignaling Lymphocytic Activation Molecule Family Member 1Signal TransductionT-Lymphocytes, RegulatorySH2D1A protein, humanSignaling Lymphocytic Activation Molecule Associated ProteinSignaling Lymphocytic Activation Molecule Family Member 1SLAMF1 protein, human

Identifiers

PMID33987447
PMCPMC8079219
OpenAlexW3155175640

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.